X4 Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	99.22	121.72	81.79	78.71	126.18	8.13	77.15	3.43	7.1
Short-Term Investments	15	0	0	0	0	0	0	0	0
Cash & Cash Equivalents	114.22	121.72	81.79	78.71	126.18	8.13	77.15	3.43	7.1
Cash Growth	-6.16%	48.82%	3.91%	-37.62%	1451.32%	-89.46%	2149.87%	-51.68%	-
Receivables	0.56	1.15	0.75	0.92	2	0	1.61	1.35	1.54
Other Current Assets	7.3	5.81	5.34	3.68	1.1	1.21	0.77	0.94	-0.25
Total Current Assets	122.08	128.68	87.88	83.31	129.28	9.34	79.53	5.72	8.39
Property, Plant & Equipment	6.4	8.33	10.22	9.2	2.36	0.24	0.42	0.52	0.76
Goodwill and Intangibles	17.35	17.35	17.35	27.11	27.11	0	0	0	0
Other Long-Term Assets	1.44	1.23	1.72	3.26	1.95	0.36	1.3	1.37	0.36
Total Long-Term Assets	25.18	26.91	29.3	39.56	31.42	0.61	1.72	1.89	1.12
Total Assets	147.26	155.59	117.18	122.87	160.7	9.94	81.25	7.6	9.51
Accounts Payable	8.95	7.78	4.28	3.14	2.09	2.97	1.89	1.65	0.42
Deferred Revenue	0	0	0	0	0	0	2.63	2.56	2.86
Current Debt	1.1	2.51	1.87	0.79	0.9	1.69	2.31	5.16	2.49
Other Current Liabilities	12.82	12.03	7.87	8.02	6.46	3.25	3.84	2.7	0.9
Total Current Liabilities	22.86	22.32	14.02	11.95	9.45	7.91	10.68	12.06	6.68
Long-Term Debt	57.18	35.91	37.92	37.66	22.02	8.15	9.92	10.13	4.7
Other Long-Term Liabilities	16.12	23.3	0.83	0.46	0.02	5.57	1.95	2.14	2.5
Total Long-Term Liabilities	73.3	59.21	38.74	38.12	22.03	13.71	11.87	12.27	7.21
Total Liabilities	96.16	81.54	52.76	50.07	31.48	21.62	22.55	24.33	13.88
Total Debt	58.28	38.42	39.79	38.45	22.91	9.83	12.24	15.29	7.19
Debt Growth	51.69%	-3.43%	3.48%	67.80%	133.05%	-19.65%	-19.97%	112.52%	-
Retained Earnings	-477.91	-376.74	-282.87	-194.18	-132.04	-79.24	-92.27	-58.39	-35.41
Comprehensive Income	-0.12	-0.12	-0.12	-0.12	-0.12	0	0.13	0.83	0.72
Shareholders' Equity	51.1	74.05	64.41	72.8	129.22	-77.09	58.71	-56.56	-34.32
Net Cash / Debt	55.94	83.3	42	40.26	103.27	-1.7	64.91	-11.86	-0.1
Net Cash / Debt Growth	-32.85%	98.32%	4.33%	-61.02%	-	-	-	-	-
Net Cash Per Share	0.31	1.31	1.63	2.01	8.96	-3.70	141.73	-138.57	-1.14
Working Capital	99.21	106.35	73.86	71.36	119.83	1.43	68.85	-6.34	1.71
Book Value Per Share	0.29	1.17	2.50	3.63	11.21	-167.94	128.18	-660.87	-404.85

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).